A constraint-first framework for future 'prompt-to-genome' AI across Bacteria, Archaea, Eukaryota, and viruses is proposed. Genome-scale models can now generate long DNA sequences, and experimentally viable genome-scale designs have begun to appear, but sequence generation alone does not establish biological feasibility. Constraints should not require designs to remain within natural sequence space; rather, they should define testable boundaries for function, inheritance, lifecycle coherence and safe use, including new-to-nature designs. We propose a two-part system. First, a Constraint Compiler translates natural-language prompts into machine-checkable specifications defining scope, context, objectives, assumptions and governance requirements. Second, a modular Validator Stack (C1-C6) evaluates candidate designs for sequence integrity, gene and regulatory plausibility, genome completeness, comparative coherence, systems-level feasibility, and safety and governance. Extreme prompts serve as stress tests to expose hidden assumptions, conflicting objectives, and refusal points, complemented by adversarial testing and risk assessment. A phased roadmap and community benchmarks are proposed to measure specification accuracy, biological feasibility, robustness, and governance performance. The goal is to move prompt-to-genome systems from impressive generation toward reliable, auditable, and accountable biological design.
No takes yet. Share an insight, caveat, or question.
Wicaksono et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: